International Clinical Trial: A Study on the Safety and Long-lasting Immunogenicity of a Domestic 9-Valent HPV Vaccine in HIV-Infected Male Recipients with Varying Degrees of Immune Reconstitution

Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124229) titled 'A Study on the Safety and Long-lasting Immunogenicity of a Domestic 9-Valent HPV Vaccine in HIV-Infected Male Recipients with Varying Degrees of Immune Reconstitution' on May 9.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Beijing Ditan Hospital, Capital Medical University

Condition: Human Papillomavirus infection

Intervention: HIV-infected group:Enroll 60 male HIV-infected individuals according to the inclusion criteria, and all study participants will receive the domestically produced 9-valent HPV vaccine (REC603)

Recruitment Status: Recruiting

Phase: 3

Date ...